Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-08-011933
Filing Date
2008-02-27
Accepted
2008-02-27 09:44:57
Documents
10
Period of Report
2008-02-26

Document Format Files

Seq Description Document Type Size
1 v105113_6-k.htm 6-K 18556
2 v105113_ex99-1.htm EX-99.1 1475
3 GRAPHIC v105113_ex99-1x1x1.jpg GRAPHIC 69216
4 GRAPHIC v105113_ex99-1x2x1.jpg GRAPHIC 68166
5 GRAPHIC v105113_ex99-1x3x1.jpg GRAPHIC 74358
6 GRAPHIC v105113_ex99-1x4x1.jpg GRAPHIC 56169
7 GRAPHIC v105113_ex99-1x5x1.jpg GRAPHIC 54073
8 GRAPHIC v105113_ex99-1x6x1.jpg GRAPHIC 55199
9 GRAPHIC v105113_ex99-1x7x1.jpg GRAPHIC 41632
10 GRAPHIC v105113_ex99-1x8x1.jpg GRAPHIC 86441
  Complete submission text file 0001144204-08-011933.txt   718742
Mailing Address
Business Address LEVEL 1 100 DORCAS STREET SOUTH MELBOURNE VIC 3205 AUSTRALIA VICTORIA C3 00000 01161396908537
PRANA BIOTECHNOLOGY LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 08644904
SIC: 2834 Pharmaceutical Preparations